Filter

1-10 of 138 results

  • The Drug Enterprise in the Age of AI

    Podcast

    AI is speeding up the search for new medicines. Can it make the discoveries themselves? Few people are better placed to answer than Dr. Elias Zerhouni. He ran the National Institutes of Health, then global R&D at Sanofi. He co-founded ModeX Therapeutics, which uses machine learning to design antibodies that don’t exist in nature, and he is now vice chairman and president of its parent company, OPKO Health. His test for AI: give it every…

  • 1115 Waiver Watch: A Look at Budget Neutrality Policy Changes

    Issue Brief

    This brief discusses key Medicaid policy changes included in CMS budget neutrality guidance and identifies open questions about how the policy changes may be clarified and how they may affect states with existing 1115 waivers or states interested in applying for new ones.

  • Building AI In-House at Europe’s Largest Hospital

    Podcast

    Most hospitals buy their AI. Charité – Universitätsmedizin Berlin, Europe’s largest academic medical center and ranked eighth in the world by Newsweek, is developing its own. Charité has consolidated its scattered AI projects into a single Institute for Artificial Intelligence in Medicine and switched on Clé, an in-house platform that runs across research, teaching, patient care, and administration. Its success, says Chief Executive Officer Prof. Dr. Heyo Kroemer, will depend on whether it improves care,…

  • Can AI Find the Cure?

    Podcast

    Medicine has its maps: Anatomists charted the body, and the Human Genome Project gave us the code. Now, the Human Cell Atlas, a global effort involving thousands of scientists, is using AI to create comprehensive reference maps of all human cells to understand human health and diagnose, monitor and treat disease. Given the extraordinary implications for drug discovery and potential cures, Chip talks with Dr. Sarah Teichmann, co-founder of the Human Cell Atlas, chair in…

  • Building the AI Hospital

    Podcast

    Walk into the emergency room at Israel’s largest hospital and the first clinician to take your history may be an AI avatar — with a physician signing off on every recommendation. Israel’s Sheba Medical Center is building what could become the first fully AI-based hospital by 2030. Dr. Eyal Zimlichman, Sheba's Chief Transformation Officer, Chief Innovation Officer and Chief AI officer, talks with Chip about what that means for patients. During their conversation, Dr. Zimlichman…

  • AI in Health Care: Who Gets Left Behind?

    Podcast

    Health care's AI future is being built right now. The open question is “for whom?” Dr. Uché Blackstock — emergency physician, former associate professor at NYU School of Medicine, founder and CEO of Advancing Health Equity, and author of The New York Times bestseller “Legacy: A Black Physician Reckons with Racism in Medicine” — joins host Chip Kahn to argue that AI governance should be shaped not only by regulators and review boards, but by…

  • AI: Does Europe Have the Answer?

    Podcast

    When health systems are stressed, Martin McKee has been there taking notes. He's spent four decades studying collapse and recovery — the post-Soviet transition, the 2008 financial crisis, the COVID-19 pandemic. Now, as professor of European public health at the London School of Hygiene and Tropical Medicine and research director of the European Observatory on Health Systems and Policies, he's turned that lens on AI. He arrives at a charged moment: America is locked in…

  • What Should Health Care Do About AI’s Lack of Guardrails?

    Podcast

    In another concerning example of AI agents going rogue recently, an OpenAI agent hacked into an Australian government website containing health care data. While some industry CEOs are calling for a slowdown and demands for regulation grow, host Chip Kahn focuses on the implications for health care when these same kinds of AI systems are already at work in hospitals — in billing, in scheduling, and increasingly in decisions about patients.

  • AI: To Regulate, or Not to Regulate?

    Podcast

    Across the tech industry, many of AI's own leaders are calling for oversight — self-imposed or from government. That debate is on, but where it will land is anyone's guess. Joe Grogan takes a different tack: the biggest threat in health care AI may not be too little regulation, but the wrong kind.

  • FDA Regulation and the Dynamic Nature of AI

    Podcast

    Dr. Brian Miller has seen medical technology regulation from every side — as a hospitalist, a former FDA official, and now an associate professor at Johns Hopkins University, where he leads a research group on market-driven approaches to FDA regulation and Medicare payment policy. In this episode, Chip talks with Miller about what happens when the FDA applies its 1976 medical device framework to AI — a technology that learns and changes.